CancerHSP: anticancer herbs database of systems pharmacology

Citations Over TimeTop 10% of 2015 papers

Abstract

The numerous natural products and their bioactivity potentially afford an extraordinary resource for new drug discovery and have been employed in cancer treatment. However, the underlying pharmacological mechanisms of most natural anticancer compounds remain elusive, which has become one of the major obstacles in developing novel effective anticancer agents. Here, to address these unmet needs, we developed an anticancer herbs database of systems pharmacology (CancerHSP), which records anticancer herbs related information through manual curation. Currently, CancerHSP contains 2439 anticancer herbal medicines with 3575 anticancer ingredients. For each ingredient, the molecular structure and nine key ADME parameters are provided. Moreover, we also provide the anticancer activities of these compounds based on 492 different cancer cell lines. Further, the protein targets of the compounds are predicted by state-of-art methods or collected from literatures. CancerHSP will help reveal the molecular mechanisms of natural anticancer products and accelerate anticancer drug development, especially facilitate future investigations on drug repositioning and drug discovery. CancerHSP is freely available on the web at http://lsp.nwsuaf.edu.cn/CancerHSP.php.

Related Papers

• → The emerging importance of predictive ADME simulation in drug discovery(2002)236 cited
• → ADME–Tox in drug discovery: integration of experimental and computational technologies(2003)181 cited
• → Applications of high-throughput ADME in drug discovery(2004)149 cited
• → ADME Optimization and Toxicity Assessment in Early- and Late-Phase Drug Discovery(2009)83 cited
• → Advantages of Good Drug-like Properties(2008)18 cited